Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumour disease

被引：0
|
作者：
Grabowski, P [1 ]
Griss, S [1 ]
Arnold, CN [1 ]
Hoersch, D [1 ]
Göke, R [1 ]
Arnold, R [1 ]
Heine, B [1 ]
Stein, H [1 ]
Zeitz, M [1 ]
Scheruebl, H [1 ]
机构：
[1] Hosp Dept Gastroenterol, Berlin, Germany
来源：
EUROPEAN JOURNAL OF ENDOCRINOLOGY | 2005年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease
    Grabowski, P
    Griss, S
    Arnold, CN
    Hörsch, D
    Göke, R
    Arnold, R
    Heine, B
    Stein, H
    Zeitz, M
    Scherübl, H
    NEUROENDOCRINOLOGY, 2005, 81 (01) : 1 - 9
  • [2] Nuclear survivin is a novel prognostic marker in neuroendocrine gastroenteropancreatic tumor disease
    Grabowski, P
    Griss, S
    Arnold, C
    Hoersch, D
    Arnold, R
    Heine, B
    Stein, H
    Zeitz, M
    Scherubl, H
    GASTROENTEROLOGY, 2004, 126 (04) : A390 - A390
  • [3] Survivin: a novel neuroendocrine marker for pheochromocytoma
    Koch, CA
    Vortmeyer, A
    Diallo, R
    Poremba, C
    Giordano, TJ
    Sanders, D
    Bornstein, SR
    Chrousos, GP
    Pacak, K
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 146 (03) : 381 - 388
  • [4] Nuclear survivin is a prognosticator in gastroenteropancreatic neuroendocrine neoplasms: a meta-analysis
    Krieg, Sarah
    Roderburg, Christoph
    Fung, Stephen
    Luedde, Tom
    Knoefel, Wolfram Trudo
    Krieg, Andreas
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (09) : 2235 - 2246
  • [5] Nuclear survivin is a prognosticator in gastroenteropancreatic neuroendocrine neoplasms: a meta-analysis
    Sarah Krieg
    Christoph Roderburg
    Stephen Fung
    Tom Luedde
    Wolfram Trudo Knoefel
    Andreas Krieg
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2235 - 2246
  • [6] Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia
    Dizdar, Levent
    Oesterwind, Kira A.
    Riemer, Jasmin C.
    Werner, Thomas A.
    Mersch, Sabrina
    Moehlendick, Birte
    Schuette, Sina C.
    Verde, Pablo E.
    Raba, Katharina
    Topp, Stefan A.
    Stoecklein, Nikolas H.
    Esposito, Irene
    Knoefel, Wolfram T.
    Krieg, Andreas
    ONCOTARGET, 2017, 8 (05) : 8369 - 8382
  • [7] Therapeutic and diagnostic implications of the somatostatin system in gastroenteropancreatic neuroendocrine tumour disease
    Höcker, M
    Wiedenmann, B
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 : S139 - S142
  • [8] The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours
    Foltyn, Wanda
    Zajecki, Wojciech
    Marek, Bogdan
    Kajdaniuk, Dariusz
    Sieminska, Lucyna
    Zemczak, Anna
    Kos-Kudla, Beata
    ENDOKRYNOLOGIA POLSKA, 2012, 63 (05) : 362 - 366
  • [9] Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
    Pape, Ulrich-Frank
    Jann, Henning
    Mueller-Nordhorn, Jacqueline
    Bockelbrink, Angelina
    Berndt, Uta
    Willich, Stefan N.
    Koch, Martin
    Roecken, Christoph
    Rindi, Guido
    Wiedenmann, Bertram
    CANCER, 2008, 113 (02) : 256 - 265
  • [10] Neuroendocrine Tumor Blood Transcript Analysis, the NETest, Predicts Gastroenteropancreatic Neuroendocrine Tumor Disease Status and Is Prognostic for Progressive Disease
    Kidd, Mark
    Pavel, Marianne
    Jann, Henning
    Prasad, Vikas
    Drozdov, Ignat
    Modlin, Irvin
    GASTROENTEROLOGY, 2016, 150 (04) : S80 - S81
12345